Have an account?
Log in to check out faster.
Your Ultimate Guide to This Weekend’s Biggest Fights
This weekend’s fight schedule is packed with high-stakes matchups, highlight-reel potential, and fighters looking to make their mark. From UFC’s flyweight showdown to Muay Thai mastery in Bangkok and bare-knuckle carnage in Albuquerque, combat sports fans have plenty to be excited about.
Below, we break down the main events in detail, including key fight stats and summaries, and highlight the most exciting undercard matchups you won’t want to miss.
Location: UFC Apex, Las Vegas, USA
Why Watch: A potential UFC Flyweight title shot is on the line.
What to Expect: A high-paced battle with dangerous striking exchanges and relentless wrestling.
Official Event Page: UFC Fight Night: Kape vs. Almabayev
A fight with serious title implications in the UFC flyweight division. Manel Kape, the former RIZIN champion, has become a knockout machine in the UFC, blending speed, power, and unpredictable striking. Asu Almabayev, a relentless Kazakh grappler, has been suffocating his opponents with non-stop takedowns and superior top control. This is the classic striker vs. wrestler battle, where Kape will try to keep the fight standing, and Almabayev will do everything in his power to drag it to the ground. If Kape lands clean, he can shut the lights off in an instant. If Almabayev gets control early, he could dominate and grind out a win.
Tale of the Tape: Kape vs. Almabayev
Streaming: ESPN+ / UFC Fight Pass
Location: Lumpinee Boxing Stadium, Bangkok, Thailand
Why Watch: Two of the best strawweight Muay Thai fighters go to war.
What to Expect: High-level striking, brutal elbows, and a relentless pace.
Official Event Page: ONE Friday Fights 98
This Muay Thai showdown pits two contrasting styles against each other. Chartpayak is a sharp, technical counter-striker with razor-sharp elbows and a measured approach. Kongchai, on the other hand, is an aggressive clinch fighter who breaks his opponents down with brutal knees and constant pressure. If Chartpayak can control the distance, he can score a knockout or outpoint Kongchai. But if Kongchai gets inside and forces a brawl, his devastating knees could end the fight early.
Tale of the Tape: Chartpayak vs. Kongchai
Location: Kiva Auditorium, Albuquerque, USA
Why Watch: The most violent combat sport on the planet delivers another high-stakes main event.
What to Expect: Blood, knockouts, and brutal hand-to-hand combat.
Official Event Page: BKFC Fight Night Albuquerque
In bare-knuckle fighting, power and durability are everything, and this matchup features two men who possess both. Keith Richardson is a pressure fighter with an iron chin and non-stop aggression, while Bekhzod Usmanov is a knockout machine with five straight first-round finishes. Usmanov will look to land early and end it quickly, while Richardson will rely on his ability to take damage and break his opponent down over time. Expect this fight to be violent, fast, and unlikely to see a decision.
Tale of the Tape: Richardson vs. Usmanov
📺 Streaming: BKFC App / FITE TV
Chairman and Chief Executive Officer M2Bio Sciences (OTC: $MRES) & Chairman and Chief Executive Officer of M2MMA (OTC:$RLAB)
February 26, 2025
In the evolving landscape of women's healthcare, Sally Maddah and Iman Chehade are leading a much-needed shift with Hiya Healthcare, addressing gaps that have long been overlooked. Their company is changing how women access critical health diagnostics, removing many of the discomforts and logistical hurdles associated with traditional medical visits. Meeting them at the Step Dubai Conference, I saw firsthand their passion for tackling one of the most underserved areas in healthcare. Their work is part of the broader FemHealthTech movement, which is bringing innovation to women’s health in previously ignored or underfunded ways.
For years, medical advancements have primarily focused on areas that neglect the specific needs of women. Reproductive health, menopause, and hormonal imbalances have often been treated as secondary concerns, leaving millions without effective diagnostic solutions. Many women avoid necessary screenings because clinical visits can be inconvenient or uncomfortable. This delay in care leads to undiagnosed conditions and long-term health consequences. Hiya Healthcare is addressing this problem by offering at-home hormone testing that allows women to take control of their health privately and at their convenience. Studies have shown that more people engage in proactive testing when healthcare solutions are easier to access, leading to earlier detection and better treatment outcomes.
Hiya Healthcare’s model prioritizes accessibility and scientific accuracy. Women begin with a digital health assessment, which collects information about their symptoms, medical history, and lifestyle. Based on their responses, a home sampling kit is provided to test key hormone levels. The sampling process is designed to be easy and minimally invasive, allowing users to collect a small blood sample in the comfort of their homes. This sample is then securely sent to a certified laboratory, where it undergoes comprehensive analysis using clinically validated testing protocols. Once the results are processed, users receive a detailed report outlining their hormonal health and evidence-based recommendations. If further medical guidance is needed, the platform connects women with certified gynecologists and endocrinologists for professional consultations.
Artificial intelligence is playing an increasingly crucial role in advancing personalized healthcare, and Hiya Healthcare is leveraging AI to enhance the accuracy and efficiency of its platform. While human expertise remains at the core, AI assists in processing vast amounts of data, identifying health patterns, and refining personalized reports. This technology allows for deeper insights into hormonal imbalances by detecting subtle variations that might be overlooked in traditional assessments. AI-driven analysis helps predict potential health risks, ensuring early intervention before symptoms worsen. The ability to detect trends over time is particularly valuable in preventing long-term complications related to hormonal disorders, metabolic imbalances, and reproductive health conditions. As AI continues to evolve, it will further enhance Hiya Healthcare’s ability to provide highly tailored health recommendations, making early detection more precise and preventative care more effective.
The necessity of proactive health management cannot be overstated. Studies show that early detection and intervention significantly reduce the risk of severe medical conditions. Women with undiagnosed hormone imbalances are more likely to experience issues such as osteoporosis, cardiovascular disease, diabetes, and infertility. Research from the Endocrine Society and the American Journal of Obstetrics & Gynecology highlights that routine hormone monitoring improves patient outcomes by allowing for earlier treatment, reducing healthcare costs, and preventing avoidable complications. The challenge has always been ensuring that people follow through with regular testing, as traditional healthcare models often place logistical or financial barriers in the way. At-home diagnostic platforms like Hiya Healthcare remove these obstacles, making it easier for women to avoid potential health concerns before they escalate.
In addition to physical health consequences, hormonal imbalances have profound effects on mental health. Research in The Lancet Psychiatry and The Journal of Clinical Endocrinology & Metabolism has established strong links between dysregulated hormone levels and mood disorders. Estrogen, progesterone, thyroid hormones, and cortisol play key roles in regulating brain chemistry, neurotransmitter function, and emotional stability. Fluctuations in these hormones can contribute to depression, anxiety, cognitive impairment, and chronic stress. For example, low estrogen levels are associated with reduced serotonin production, which can lead to depressive symptoms, irritability, and mood swings. Similarly, hypothyroidism—characterized by insufficient thyroid hormone production—has been linked to increased rates of depression, brain fog, and fatigue. Chronic hormonal imbalances also disrupt the hypothalamic-pituitary-adrenal (HPA) axis, a key stress-regulation system, leading to heightened cortisol levels and an increased risk of anxiety disorders. Early detection of these imbalances allows for timely intervention through lifestyle modifications, nutritional support, and, when necessary, hormone therapy, significantly improving mental well-being.
Hiya Healthcare is not stopping at hormone testing. The subsequent iterations of the platform will include expanded diagnostics, allowing women to test for sexually transmitted infections (STDs), vaginal microbiome imbalances, and other key markers of reproductive and general health. The ability to conduct these tests at home will significantly improve access to early detection for infections that often go unnoticed due to lack of symptoms. Future integrations will include AI-driven health tracking, allowing users to monitor hormonal fluctuations over time and receive continuous, adaptive recommendations based on new findings. These advancements will enable a more comprehensive, data-driven approach to women's health, ensuring each user receives proactive, personalized care that evolves alongside their needs.
The traditional healthcare system has long been structured around reactive treatment, addressing medical issues only after they become problematic. Hiya Healthcare is shifting this paradigm toward preventative, patient-driven healthcare, empowering women to take charge of their well-being before slight imbalances become serious health concerns. The platform bridges the gap between convenience and clinical-grade accuracy by integrating advanced diagnostics with AI-enhanced analysis. Women no longer have to choose between access and quality—Hiya Healthcare proves that both can coexist to benefit patients and improve public health.
This is the future of women's health. By combining science, technology, and accessibility, Hiya Healthcare is redefining what it means to take control of one’s well-being. The company is setting a new standard in FemHealthTech, proving that innovation in diagnostic medicine is not just about improving healthcare but fundamentally reshaping how women engage with their health.
I'm a big fan of their vision and plan to help them execute it. They are swinging for the fences, and if they hit a home run, the impact will be extraordinary—not just for investors but also for millions of women who deserve better healthcare solutions.
Chairman and Chief Executive Officer M2Bio Sciences (OTC: $MRES) & Chairman and Chief Executive Officer of M2MMA (OTC:$RLAB)
February 27, 2025
Recent advancements in artificial intelligence (AI) for mental health diagnostics have led to the development of AI-powered facial screening technology, which analyzes microexpressions, muscle movements, and autonomic nervous system responses to detect early indicators of mental health disorders. This non-invasive method enables objective, data-driven assessments of mood disorders, anxiety, and neurocognitive impairments, improving diagnostic accuracy and reducing reliance on subjective evaluations. AI can identify subtle physiological patterns associated with emotional states by integrating machine learning algorithms with real-time facial analysis. This makes it a promising tool for early intervention and personalized treatment planning in psychiatric care.
At M2MMA, we are committed to protecting the athlete, developing protocols for concussion mitigation, and building the world's first comprehensive brain database that will serve as a universal resource for neurological health across all sports. Our approach integrates AI-driven facial analysis with sound-based AI algorithms to enhance real-time monitoring of fighter safety during competition. By analyzing facial muscle distortions, involuntary reflexes, and transient microexpressions, we can detect signs of potential neurological distress or impact-related trauma. The system synchronizes this data with acoustic analysis, evaluating impact force, frequency, and tonal shifts in sound responses to assess their biomechanical and physiological effects. This enables early detection of potential concussive injuries and neurophysiological stress.
Beyond combat sports, our brain database is designed to be a globally accessible knowledge hub for neurological health, functioning much like a Google search engine for the brain. This resource will compile data from athletes in all sports, medical case studies, and clinical research, offering insights into head trauma, recovery timelines, cognitive decline, and brain resilience. It will serve scientists, doctors, researchers, sports organizations, and governing bodies by providing real-time data on brain health, enabling evidence-based decision-making in concussion protocols and neurological safety measures. M2MMA is focused on mitigating concussions and chronic traumatic encephalopathy (CTE) by refining detection methods, improving safety protocols, and driving research into long-term neurological health.
By integrating AI-based monitoring with large-scale scientific research, M2MMA drives a data-driven revolution in athlete safety. The brain database project will track neurological changes over time, allowing for better injury prevention strategies and optimizing athlete longevity. AI-powered facial screening, sound analysis, and real-time injury assessment are shaping the future of mental health and sports medicine. These innovations will enhance early diagnosis, improve treatment strategies, and revolutionize safety protocols, ensuring that athletes and individuals at risk of neurological conditions receive the highest level of care.🧠❤️
M2MMA is a revolutionary combat sports promotion that transforms the industry through cutting-edge innovation, advanced technology, and a steadfast commitment to athlete welfare. By integrating artificial intelligence, data-driven insights, and forward-thinking strategies, M2MMA enhances athlete safety, optimizes performance, and redefines the fan experience. Focusing on community engagement and fostering a dynamic future for combat sports, M2MMA stands at the intersection of technology and tradition, driving progress while honoring the sport's rich heritage.
The company is publicly traded on the Over-the-Counter Bulletin Board (OTCBB) of NASDAQ under the ticker symbol "RLAB."
RLAB/M2MMA is majority controlled by M2Bio Sciences, which is also publicly traded on the Over-the-Counter market under the ticker symbol (OTC Pink: MRES)
GENERAL MANAGER OF M2MMA
